|
Age (yrs)
|
53.5 (39 to 61.5)
|
|
Female sex (%)
|
95
|
|
Disease duration (yrs)
|
3 (2 to 6)
|
|
Erosions (%)
|
44
|
|
Subcutanous nodules (%)
|
7
|
|
DAS28
|
4.72 (3.8 to 6.4)
|
|
Morning stiffness (minutes)
|
30 (10 to 60)
|
|
VAS-pain (0 to10)
|
5 (3 to 7)
|
|
CRP (mg/L)
|
12 (6 to 35)
|
|
Tobacco, N (%)
|
1 (2)
|
|
Prednisone, N (%)
|
51 (91)
|
|
Dose (mg/day)
|
10
|
|
Methotrexate, N (%)
|
43 (77)
|
|
Dose (mg/day)
|
10
|
|
Sulfasalazine, N (%)
|
7 (12)
|
|
Azathioprine, N (%)
|
2 (5)
|
|
Leflunomide, N (%)
|
2 (5)
|
|
D-penicillamine, N (%)
|
1 (2)
|
- Continuous values are presented as median (interquartile range 25 to 75); CRP, C-reactive protein; DAS, disease activity score; VAS, visual analogue score
